Collagen-povidone for Diabetic Seniors' Tenosynovitis - Trial NCT06396819
Access comprehensive clinical trial information for NCT06396819 through Pure Global AI's free database. This Phase 4 trial is sponsored by Instituto Mexicano del Seguro Social and is currently Completed. The study focuses on Diabetes Complications. Target enrollment is 25 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Instituto Mexicano del Seguro Social
Timeline & Enrollment
Phase 4
Jan 01, 2023
Apr 01, 2024
Primary Outcome
Mean evolution time of tenosynovitis
Summary
Diabetes affects 415 million adults globally, leading to hand issues. Povidone collagen shows
 promise in managing tenosynovitis. A clinical trial was conduced to compared its efficacy in
 adults over 60. It is shown that the intervention reduces pain, improves functionality, and
 grip strength with no complications. Collagen povidone holds potential for treating diabetic
 hand issues.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06396819
Non-Device Trial